FTC Approves $5.4B Eli Lilly-Novartis Deal With Divestiture
By Melissa Lipman ( December 22, 2014, 3:09 PM EST) -- The Federal Trade Commission on Monday cleared Eli Lilly & Co.'s $5.4 billion acquisition of Novartis AG's animal health unit on the condition that Eli Lilly shed Novartis' heartworm treatment product line....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.